Table 2.

Inter-group Comparison Between Patients with Hepatic or Neurologic Presentation

	Hepatic	Neurologic	Statistical significance
Age at diagnosis (Years)	19 ± 9	28 ± 12	n.s.
Age at onset (Years)	17 ± 7	24 ± 11	n.s.
Serum Cpl (mg/L)	13 ± 6	9 ± 4	P=0.048
Hepatic copper (mg/g)	697 ± 596	557 ± 559	n.s.
Gender	8m 11f	5m 5f	n.s.
KFR	12(−) 7(+)	0(−) 10(+)	P=0.0103
Rhodanine	9(+) 8(−)	4(+) 5(−)	n.s.

Groups were compared using two-sample, two-tailed t tests assuming unequal variances, or by Chi-Square analysis.